Overcoming cancer therapeutic bottleneck by drug repurposing

Z Zhang, L Zhou, N Xie, EC Nice, T Zhang… - Signal transduction and …, 2020 - nature.com
Ever present hurdles for the discovery of new drugs for cancer therapy have necessitated
the development of the alternative strategy of drug repurposing, the development of old …

The Multifaceted p21 (Cip1/Waf1/CDKN1A) in Cell Differentiation, Migration and Cancer Therapy

NN Kreis, F Louwen, J Yuan - Cancers, 2019 - mdpi.com
Loss of cell cycle control is characteristic of tumorigenesis. The protein p21 is the founding
member of cyclin-dependent kinase inhibitors and an important versatile cell cycle protein …

Targeting autophagy using natural compounds for cancer prevention and therapy

S Deng, MK Shanmugam, AP Kumar, CT Yap, G Sethi… - Cancer, 2019 - Wiley Online Library
Autophagy, also known as macroautophagy, is a tightly regulated process involved in the
stress responses, such as starvation. It is a vacuolar, lysosomal pathway for the degradation …

Targeting tumor hypoxia and mitochondrial metabolism with anti-parasitic drugs to improve radiation response in high-grade gliomas

F Mudassar, H Shen, G O'Neill, E Hau - Journal of Experimental & Clinical …, 2020 - Springer
Abstract High-grade gliomas (HGGs), including glioblastoma and diffuse intrinsic pontine
glioma, are amongst the most fatal brain tumors. These tumors are associated with a dismal …

[HTML][HTML] Selective autophagy regulates cell cycle in cancer therapy

K Zheng, Z He, K Kitazato, Y Wang - Theranostics, 2019 - ncbi.nlm.nih.gov
Aberrant function of cell cycle regulators results in uncontrolled cell proliferation, making
them attractive therapeutic targets in cancer treatment. Indeed, survival of many cancers …

The p53/p21 complex regulates cancer cell invasion and apoptosis by targeting Bcl-2 family proteins

EM Kim, CH Jung, J Kim, SG Hwang, JK Park, HD Um - Cancer research, 2017 - AACR
The tumor suppressor p53 binds prosurvival Bcl-2 family proteins such as Bcl-w and Bcl-XL
to liberate Bax, which in turn exerts proapoptotic or anti-invasive functions depending on …

Autophagy: a druggable process

E Morel, M Mehrpour, J Botti, N Dupont… - Annual Review of …, 2017 - annualreviews.org
Macroautophagy (hereafter called autophagy) is a vacuolar, lysosomal pathway for
catabolism of intracellular material that is conserved among eukaryotic cells. Autophagy …

Recent advance of herbal medicines in cancer-a molecular approach

M Ali, SUD Wani, M Salahuddin, SN Manjula… - Heliyon, 2023 - cell.com
Bioactive compounds are crucial for an extensive range of therapeutic uses, and some
exhibit anticancer activity. Scientists advocate that phytochemicals modulate autophagy and …

Phytochemicals as a complement to cancer chemotherapy: pharmacological modulation of the autophagy-apoptosis pathway

MA Rahman, MA Hannan, R Dash… - Frontiers in …, 2021 - frontiersin.org
Bioactive plant derived compounds are important for a wide range of therapeutic
applications, and some display promising anticancer properties. Further evidence suggests …

Repurposing quinacrine for treatment-refractory cancer

DB Oien, CL Pathoulas, U Ray, P Thirusangu… - Seminars in Cancer …, 2021 - Elsevier
Quinacrine, also known as mepacrine, has originally been used as an antimalarial drug for
close to a century, but was recently rediscovered as an anticancer agent. The mechanisms …